FDA's vaccines leader on 2022 priorities & pharma contributions to lawmakers

Taking stock of the drug industry, from the lab to the medicine chest  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: FDA's vaccines and biologics chief talks Covid-19, 2022 priorities, and getting back to gene, cell therapy review By Nicholas Florko Jim Lo Scalzo/Pool via AP The FDA's Center for Biologics Evaluation and Research is hoping 2022 is the year it can get back to normal. Read More STAT+: Some drug makers quietly resumed donations to lawmakers who denied Biden's election victory By Ed Silverman Adobe The companies "ditched their purported values" and were “quick to forgive and forget” the lawmakers, a watchdog group argues. Read More Covid-19 politics force state lawmakers to ponder pharma campaign cash By Rachel Cohrs Cindy Ord/Getty Images for Pfizer/BioNTech Rep. Beth Liston, an Ohio state lawmaker, supports Covid vaccines. But polarized politics led her to refuse contributions from their makers. Read More Sponsor content by THE PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) Drug manufacturers pointing fingers…again With Congress poised to fully repeal the rebate rule and prevent significant increases in both Medicare beneficiary premiums and Medicare Part D program costs, pharmaceutical industry representatives are once again attempting to divert attention by suggesting so-called point of sale rebate policies that would undo this progress. We urge Congressional negotiators to continue to resist the latest attempts to shift the blame that puts profits over patients. Opinion: Opioid overdoses are killing Americans. Improving access to methadone can save lives By Donald Norcross David Keyton/AP The Opioid Treatment Access Act would improve access to and modernize the delivery of methadone for people with opioid use disorder. Read More Tuesday, January 4, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser